BioArctic ABBRCTF 84 Interest Coverage is 396.95 as of Mar. 2026, which is 23% below its 10-year median of 514.85. GuruFocus rates BRCTF with a GF Score™ of 84/100 and a GF Value™ of $53.07 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 377 Biotechnology companies, BioArctic AB ranks worse than 70.29% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. BioArctic AB's
Operating Income
for the
three
months ended in Mar. 2026 was $22.6 Mil. BioArctic AB's Interest Expense for the
three
months ended in Mar. 2026 was $-0.1 Mil.
BioArctic AB's interest coverage for the quarter that ended in Mar. 2026 was 396.95.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for BioArctic AB's Interest Coverage or its related term are showing as below:
BRCTF'
s Interest Coverage Range Over the Past 10 Years
Min: 16.3 Med: 514.85 Max: 12120.2
Current: 16.3
BRCTF's Interest Coverage is ranked worse than 70.29% of 377
companies
in the Biotechnology industry
Industry Median: 106.07
vs BRCTF: 16.30
BioArctic AB (OTCPK:BRCTF) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
BioArctic AB Interest Coverage Related Terms
BioArctic AB Interest Coverage Historical Data
* Premium members only.
The historical data trend for BioArctic AB's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
BRCTF vs VRTX, REGN, ALNY: Interest Coverage Comparison
For the Biotechnology subindustry, BioArctic AB's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioArctic AB Interest Coverage vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, BioArctic AB's Interest Coverage distribution charts can be found below:
* The bar in red indicates where BioArctic AB's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioArctic AB (BRCTF) has a Interest Coverage of 396.95 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on BioArctic AB and its competitors. This is 23% below median its historical median of 514.85. Over the past decade, BioArctic AB's Interest Coverage has ranged from 16.30 to 12,120.20. According to the industry distribution chart, BioArctic AB ranks #265 out of 377 companies in the Biotechnology industry, placing it in the top 70.3%.
Is BioArctic AB's Interest Coverage too high?
BioArctic AB's current Interest Coverage of 396.95 is 23% below median its 10-year median of 514.85. Over the past 10 years, this metric has ranged from a low of 16.30 to a high of 12,120.20. The Biotechnology industry median Interest Coverage is 106.07. BioArctic AB's value of 396.95 is 274.2% above this industry median. Based on the distribution chart, BioArctic AB ranks #265 out of 377 companies in the Biotechnology industry, which is below the industry midpoint. Overall, BioArctic AB has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does BioArctic AB's Interest Coverage compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, BioArctic AB ranks #265 out of 377 companies for Interest Coverage. This places BioArctic AB in the lower half of its industry. The industry median Interest Coverage is 106.07. BioArctic AB's value of 396.95 is 274.2% above this benchmark. Historically, BioArctic AB's own Interest Coverage has ranged from 16.30 to 12,120.20 over the past decade. While the company's 10-year median is 514.85 vs. the industry median of 106.07, BioArctic AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Biotechnology company?
The median Interest Coverage among Biotechnology companies is 106.07, based on 377 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BioArctic AB's current Interest Coverage of 396.95 is 274.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on BioArctic AB and its competitors. For the Biotechnology industry, the median Interest Coverage is 106.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BioArctic AB's current Interest Coverage is 396.95, which is 23% below median its own 10-year median of 514.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioArctic AB stock overvalued right now?
Based on GuruFocus' analysis, BioArctic AB (BRCTF) is currently considered Modestly Undervalued. The stock's GF Value™ is $53.07, compared to a current price of $35.00 — trading 34% below its estimated fair value. The current Interest Coverage is 396.95, which is 23% below median its 10-year median of 514.85 and 274.2% above the Biotechnology industry median of 106.07. BioArctic AB's overall GF Score™ is 84/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For BioArctic AB (BRCTF), the current Interest Coverage is 396.95 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BioArctic AB (BRCTF) Overvalued in 2026?
Based on GuruFocus' analysis, BioArctic AB stock appears to be undervalued.
The current stock price of $35.00 is trading 34% below its estimated GF Value™ of $53.07.
GuruFocus considers BioArctic AB to be Modestly Undervalued.
Key valuation signals for BRCTF:
Interest Coverage: 396.95 (23% below median its 10-year median of 514.85)
GF Value™: $53.07 vs. price of $35.00 (34% below fair value)
Industry Position: 274.2% above the Biotechnology median (#265 of 377)
No single metric tells the full story. See the BRCTF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. Geographically, it derives a majority of its revenue from North America.
84GF Score
Get the complete analysis for BRCTF
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BRCTF has been successfully added to your 
